View in EDS

Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT).

Saved in:
Bibliographic Details
Title: Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT).
Authors: Mullol J; Rhinology Unit & Smell Clinic, Department of Otorhinolaryngology, Hospital Clinic Barcelona, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Catalonia, Spain., Han JK; Department of Otolaryngology, Head and Neck Surgery, Eastern Virginia Medical School, Norfolk, Virginia, USA., Laidlaw TM; Division of Allergy and Clinical Immunology, Department of Medicine, Jeff and Penny Vinik Center for Translational Immunology Research, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Hopkins C; Department of Otolaryngology-Head and Neck Surgery, Guy's and St Thomas' Hospital, London, UK., Peters AT; Division of Allergy and Immunology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Pfaar O; Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps University of Marburg, Marburg, Germany., Desrosiers M; Division of Otolaryngology, Head and Neck Surgery, Centre Hospitalier de L'Université de Montréal, University of Montreal, Montreal, Quebec, Canada., Lee SE; Division of Otolaryngology, Head and Neck Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Lane AP; Department of Otolaryngology, Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland, USA., Chen C; Biometrics, Late-stage Development, Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland, USA., Chon Y; Global Biostatistical Science, Amgen, Thousand Oaks, California, USA., Ponnarambil SS; Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Foster A; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland, USA., Lindsley AW; US Medical Affairs, Amgen, Thousand Oaks, California, USA., Ambrose CS; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland, USA.
Source: International forum of allergy & rhinology [Int Forum Allergy Rhinol] 2026 May; Vol. 16 (5), pp. 484-494. Date of Electronic Publication: 2026 Jan 06.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study
Journal Info: Publisher: Published for ARS-AAOA by Wiley-Blackwell Country of Publication: United States NLM ID: 101550261 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2042-6984 (Electronic) Linking ISSN: 20426976 NLM ISO Abbreviation: Int Forum Allergy Rhinol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41493192
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mullol+J%22">Mullol J</searchLink>; Rhinology Unit & Smell Clinic, Department of Otorhinolaryngology, Hospital Clinic Barcelona, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Catalonia, Spain.<br /><searchLink fieldCode="AU" term="%22Han+JK%22">Han JK</searchLink>; Department of Otolaryngology, Head and Neck Surgery, Eastern Virginia Medical School, Norfolk, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Laidlaw+TM%22">Laidlaw TM</searchLink>; Division of Allergy and Clinical Immunology, Department of Medicine, Jeff and Penny Vinik Center for Translational Immunology Research, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Hopkins+C%22">Hopkins C</searchLink>; Department of Otolaryngology-Head and Neck Surgery, Guy's and St Thomas' Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Peters+AT%22">Peters AT</searchLink>; Division of Allergy and Immunology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Pfaar+O%22">Pfaar O</searchLink>; Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps University of Marburg, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Desrosiers+M%22">Desrosiers M</searchLink>; Division of Otolaryngology, Head and Neck Surgery, Centre Hospitalier de L'Université de Montréal, University of Montreal, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Lee+SE%22">Lee SE</searchLink>; Division of Otolaryngology, Head and Neck Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Lane+AP%22">Lane AP</searchLink>; Department of Otolaryngology, Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Chen+C%22">Chen C</searchLink>; Biometrics, Late-stage Development, Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Chon+Y%22">Chon Y</searchLink>; Global Biostatistical Science, Amgen, Thousand Oaks, California, USA.<br /><searchLink fieldCode="AU" term="%22Ponnarambil+SS%22">Ponnarambil SS</searchLink>; Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Foster+A%22">Foster A</searchLink>; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Lindsley+AW%22">Lindsley AW</searchLink>; US Medical Affairs, Amgen, Thousand Oaks, California, USA.<br /><searchLink fieldCode="AU" term="%22Ambrose+CS%22">Ambrose CS</searchLink>; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101550261%22">International forum of allergy & rhinology</searchLink> [Int Forum Allergy Rhinol] 2026 May; Vol. 16 (5), pp. 484-494. <i>Date of Electronic Publication: </i>2026 Jan 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Published+for+ARS-AAOA+by+Wiley-Blackwell%22">Published for ARS-AAOA by Wiley-Blackwell </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101550261 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2042-6984 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220426976%22">20426976 </searchLink><i>NLM ISO Abbreviation: </i>Int Forum Allergy Rhinol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41493192
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/alr.70090
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 484
    Titles:
      – TitleFull: Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mullol J
      – PersonEntity:
          Name:
            NameFull: Han JK
      – PersonEntity:
          Name:
            NameFull: Laidlaw TM
      – PersonEntity:
          Name:
            NameFull: Hopkins C
      – PersonEntity:
          Name:
            NameFull: Peters AT
      – PersonEntity:
          Name:
            NameFull: Pfaar O
      – PersonEntity:
          Name:
            NameFull: Desrosiers M
      – PersonEntity:
          Name:
            NameFull: Lee SE
      – PersonEntity:
          Name:
            NameFull: Lane AP
      – PersonEntity:
          Name:
            NameFull: Chen C
      – PersonEntity:
          Name:
            NameFull: Chon Y
      – PersonEntity:
          Name:
            NameFull: Ponnarambil SS
      – PersonEntity:
          Name:
            NameFull: Foster A
      – PersonEntity:
          Name:
            NameFull: Lindsley AW
      – PersonEntity:
          Name:
            NameFull: Ambrose CS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2026 May
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2042-6984
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: International forum of allergy & rhinology
              Type: main
ResultId 1